T 1255/13 (CTLA4 production/BRISTOL-MYERS SQUIBB) of 02.07.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T125513.20190702
- Date of decision
- 2 July 2019
- Case number
- T 1255/13
- Petition for review of
- -
- Application number
- 03808535.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PRODUCT QUALITY ENHANCEMENT IN MAMMALIAN CELL CULTURE PROCESSES FOR PROTEIN PRODUCTION
- Applicant name
- Bristol-Myers Squibb Company
- Opponent name
- Patentanwälte Isenbruck Bösl Hörschler PartG mbB
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- "Main Request - requirements of the EPC met (yes)"
- Catchword
- -
- Cited cases
- -
- Citing cases
- T 2911/19
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent as amended in the following version:
Description:
Pages 3 - 42 of the patent specification.
Claims:
1 to 9 of the main request filed under cover of a letter dated 10 May 2019.
Drawings, Figures:
1 -19 of the patent specification.
3. The request for apportionment of costs is refused.